TABLE 4.
MICs of MSI-78 for 61 anaerobic bacteria and rates of susceptibility to MSI-78 and six other antibiotics
| Microorganism | No. | MSI-78 MIC (μg/ml) | % of isolates for which MSI-78 MICs were ≤64 μg/ml | % of isolates susceptible toa: | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Geometric mean | Range | OFLX | CFOX | CLIN | MET | PEN | PIP | |||
| Bacteroides fragilis | 6 | 5.6 | 4–8 | 100 | 67 | 100 | 83 | 100 | 0 | 67 | 
| Bacteroides ovatus | 7 | 5.9 | 4–8 | 100 | 0 | 29 | 43 | 100 | 0 | 29 | 
| Bacteroides ureolyticus | 3 | 0.4 | 0.25–0.5 | 100 | 33 | 100 | 100 | 100 | 100 | 100 | 
| Bacteroides vulgatus | 6 | 4.0 | 4–4 | 100 | 83 | 33 | 83 | 100 | 0 | 17 | 
| Clostridium difficile | 4 | 1.7 | 0.5–4 | 100 | 25 | 0 | 100 | 100 | 100 | 100 | 
| Clostridium perfringens | 5 | 18.4 | 8–32 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 
| Clostridium ramosum | 2 | 16 | 16–16 | 100 | 0 | 100 | 0 | 100 | 100 | 100 | 
| Clostridium sporogenes | 2 | 6 | 8–32 | 100 | 100 | 100 | 0 | 100 | 100 | 100 | 
| Clostridium sp. | 1 | 32 | 100 | 100 | 100 | 0 | 100 | 100 | 100 | |
| Peptostreptococcus anaerobius | 6 | 45 | 32–64 | 100 | 100 | 100 | 100 | 100 | 33 | 100 | 
| Peptostreptococcus asaccharolyticus | 3 | 5 | 4–8 | 100 | 0 | 100 | 100 | 100 | 67 | 100 | 
| Peptostreptococcus magnus | 4 | 0.7 | 0.5–1 | 100 | 0 | 100 | 75 | 100 | 100 | 100 | 
| Prevotella bivia | 9 | 69 | 32–128 | 78 | 100 | 100 | 100 | 100 | 22 | 100 | 
| Prevotella melaninogenica | 3 | 51 | 32–64 | 100 | 33 | 100 | 100 | 100 | 33 | 100 | 
Abbreviations (susceptibility breakpoints are in parentheses): OFLX, ofloxacin (≤2.0 μg/ml); CFOX, cefoxitin (≤16 μg/ml); CLIN, clindamycin (≤2.0 μg/ml); MET, metronidazole (≤8.0 μg/ml); PEN, penicillin G (≤0.5 μg/ml); PIP, piperacillin (≤32 μg/ml).